A single positive HIV viral load test often falsely identified HIV infection in people who were using long-acting cabotegravir (Apretude) for preexposure prophylaxis (PrEP), according to results from ...

A milliliter of blood contains about 15 individual drops. For a person with human immunodeficiency virus (HIV), each drop of blood could contain anywhere from fewer than 20 copies of the virus to more ...

After developing a COVID-19 vaccine in record time, Moderna is teaming up with San Diego scientists to use the biotech’s technology to make shots against HIV, one of the world’s most complex and ...

If the source person's HIV screening test result is negative but there has been a risk for HIV exposure in the previous 6 weeks, plasma HIV RNA testing of the source person is also recommended. In ...

This retrospective study evaluated real-world implementation of the updated CDC HIV algorithm in a large US laboratory. Objectives: To understand real-world implementation of the updated CDC HIV ...

HIV is one of the world's most serious public health challenges, and molecular detection plays a significant role in early diagnosis and antiretroviral therapy for HIV patients. The current "gold ...

Please provide your email address to receive an email when new articles are posted on . In a trial assessing cabotegravir for HIV PrEP, the long-acting injectable appeared to delay the detection of a ...

HIV anti-retroviral therapy is considered a treatment and not a cure because patients usually carry a reservoir of HIV-infected cells that can re-emerge if treatment stops. These reservoirs have long ...